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ABSTRACT
Fusobacterium nucleatum is a Gram-negative oral commensal anaerobe which has been increas-
ingly implicated in various gastrointestinal (GI) disorders, including inflammatory bowel disease, 
appendicitis, GI cancers. The oral cavity harbors a diverse group of Fusobacterium, and it is 
postulated that F. nucleatum in the GI tract originate from the mouth. It is not known, however, if 
all oral Fusobacterium translocate to the GI sites with equal efficiencies. Therefore, we amplified 16S 
rRNA genes of F. nucleatum and F. periodonticum, two closely related oral species from matched 
saliva, gastric aspirates, and colon or ileal pouch aspirates of three patients with inflammatory 
bowel disease (IBD) and three healthy controls, and saliva alone from seven patients with either 
active IBD or IBD in remission. The 16S rRNA gene amplicons were cloned, and the DNA sequences 
determined by Sanger sequencing. The results demonstrate that fusobacterial community compo-
sition differs more significantly between the oral and GI sites than between different individuals. 
The oral communities demonstrate the highest level of variation and have the richest pool of 
unique sequences, with certain nodes/strains enriched in the GI tract and others diminished during 
translocation. The gastric and colon/pouch communities exhibit reduced diversity and are more 
closely related, possibly due to selective pressure in the GI tract. This study elucidates selective 
translocation of oral fusobacteria to the GI tract. Identification of specific transmissible clones will 
facilitate risk assessment for developing Fusobacterium-implicated GI disorders.
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Introduction
Genus Fusobacterium are Gram-negative obligate 
anaerobic bacilli with tapered or fusiform ends and 
produce butyrate as a metabolic end product. There 
are currently 13 species, among which Fusobacterium 
nucleatum and Fusobacterium periodonticum are two 
closely related species that normally dwell in the oral 
cavity.1 Under diseased conditions, however, they can 
translocate to extra-oral sites causing infection and 
inflammation.2 F. nucleatum is one of the most pre-
valent species isolated from human infections, having 
been implicated in atherosclerosis, adverse pregnancy 
outcomes, rheumatoid arthritis, and organ abscesses 
and infections.3 In recent years, F. nucleatum has been 
increasingly associated with GI disorders, including 
inflammatory bowel disease (IBD), appendicitis, and 
esophageal, pancreatic, and colorectal cancers 
(CRC).3–13 The presence of F. nucleatum in cancers 
is often associated with worse forms and poor 
prognosis.4,13–15 F. nucleatum colonizes and invades 
CRC cells and stimulates cancer growth through 
binding of its unique FadA adhesin to E-cadherin.16 
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It modulates the tumor micro-environment, confers 
chemoresistance, and promotes CRC metastasis.17–21 
F. nucleatum exacerbates CRC progression via 
a positive feedback loop between FadA and Annexin 
A1, which then activates Wnt/β-catenin signaling.22 
Although F. nucleatum can disseminate through 
hematogenous transmission,23,24 studies have demon-
strated enrichment of F. nucleatum and fadA gene in 
the fecal microbiome of CRC patients compared to 
the normal controls, suggesting translocation through 
the GI tract.20,25,26
F. nucleatum is a highly diverse species, consist-
ing of five subspecies: animalis, fusiforme, nucle-
atum, polymorphum, and vincentii.1 Each 
individual may harbor multiple strains of different 
subspecies in the oral cavity. It was reported that 
up to seven different genotypes could be detected 
in the same oral cavity and up to four different 
genotypes were observed within a single site.27 
Previous report showed that F. nucleatum detected 
in intrauterine infection predominantly belongs to 
subspecies animalis, followed by subsp 
polymorphum.2 F. nucleatum subsp animalis, poly-
morphum, nucleatum, and vincentii have all been 
detected in CRC.28,29 When matched saliva and 
CRC samples were analyzed, more Fusobacterium 
strains were detected in saliva than in CRC.28 
These observations suggest that not all 
Fusobacterium disseminate to extra-oral sites 
with equal efficiencies.
16S rRNA is often used to identify species. 
Microorganisms with >97% sequence identity of 
16S rRNA gene are considered the same species.30 
However, even within species of closer than 97% 
similarity, there can be significant variations, which 
may account for differences in host specificity31 and 
ecological niche.32 There is considerable genomic 
variability among F. nucleatum, with the average 
nucleotide identity (ANI) between subspecies of 
less than 93%.33 Thus, it is important to not only 
distinguish between subspecies, but also identify 
relevant strains within the subspecies.
In this study, we examine the abundance pat-
terns of different Fusobacterium in matching 
samples of saliva and GI (gastric, colon, and 
ileal pouch) aspirates from IBD patients and 
healthy controls. We accomplish this by using 
Minimum Entropy Decomposition (MED) to 
assemble representative sequences of Sanger- 
sequenced 16S rRNA genes. We reveal that 
Fusobacterium translocate through the GI tract 
in distinct sub-communities. Investigation of 
transmissible strains will help identify unique 




Matching samples of saliva, gastric aspirate, and 
colon or ileal pouch aspirate were collected from 
three IBD patients and three healthy controls at the 
endoscopy suite at Cleveland Clinic in Cleveland, 
Ohio (Table 1). Saliva was collected prior to the 
endoscopy procedures by having the patients spit 
into sterile collection vials. Gastric aspirates were 
collected during endoscopy, and colon or ileal 
pouch aspirates were collected during colonoscopy, 
respectively. The ileal pouch is made from a loop of 
distal ileum that serves as a fecal reservoir in 
patients with colectomy (i.e. removal of colon) 
resulting from ulcerative colitis. The patients 





1 saliva, gastric aspirate, colon 
aspirate
Healthy participant Healthy
2 saliva, gastric aspirate, colon 
aspirate
Healthy participant Healthy
3 saliva, gastric aspirate, colon 
aspirate
Healthy participant Healthy










6 saliva, gastric aspirate, pouch 
aspirate
CD of stomach and 
colon
IBD
2667 saliva Normal pouch IBD*
2704 saliva Normal pouch IBD*
2714 saliva Normal pouch IBD*
2674 saliva Pouchitis IBD
2678 saliva CD of pouch IBD
2705 saliva CD of pouch IBD
2706 saliva CD of pouch IBD
aSaliva was collected by patients spitting into collection vials in the endo-
scopy suite prior to the endoscopy procedures. Gastric and colon or ileal 
pouch aspirates were collected during the endoscopy and colonoscopy 
procedures, respectively. 
bIleal pouch is made from a loop of distal ileum that serves as a fecal reservoir 
in patients with colectomy (i.e. removal of colon) resulting from ulcerative 
colitis. Pouchitis is the nonspecific inflammation of the ileum reservoir with 
bacterial etiology. Due to the pouch surgery, some patients with 
a preoperative diagnosis of ulcerative colitis may develop de novo 
Crohn’s disease (CD) of the pouch. In contrast to bacterial etiology of 
pouchitis, CD of the pouch is believed to result from a combination of 
factors of autoimmune, surgical ischemia, and microbiome. Pouchitis along 
with CD and UC are all considered as different forms of IBD. 
*In remission.
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underwent polyethylene glycol-based colonic pre-
paration prior to colonoscopy. Saliva alone was also 
collected from seven additional IBD patients (Table 
1). All samples were stored at −80°C until use. This 
study was approved by the Internal Review Board at 
Cleveland Clinic (IRB 06–673). Written informed 
consent was obtained prior to patient enrollment 
and sample collection. The specimens were de- 
identified before being analyzed at Columbia 
University.
DNA extraction, PCR, cloning, and DNA sequencing
DNA from saliva and gastric aspirates was 
extracted by the phenol/chloroform/isoamyl alco-
hol method.34 Briefly, the samples were centri-
fuged, and the pellets were collected and dissolved 
in lysis buffer (10 mM Tris HCl pH8.0, 1 mM 
EDTA, 1% SDS). After adding one volume of phe-
nol:chloroform:isoamyl alcohol (25:24:1), the sam-
ples were transferred to tubes containing glass- 
beads (Microbead tubes, MO BIO, Carlsbad, CA, 
USA) and beaten vigorously for 2 min and repeat 5 
times. Following centrifugation, the upper aqueous 
phase was collected, mixed with 0.5 volume of 
7.5 M NH4OAc and -2.5 volume of 100% ethanol, 
and stored at –20°C overnight before centrifugation 
to precipitate DNA. The DNA pellets were washed 
with 70% ethanol and resuspended in TE buffer. 
DNA was cleaned further using Genomic DNA 
Clean and Concentrator Kit (ZYMO Research, 
Irvine, CA, USA) following the manufacturer’s 
instructions. QIAamp Fast DNA Stool Mini Kit 
(Qiagen, Hilden, Germany) was used to extract 
DNA from colon/pouch aspirates because it can 
effectively remove PCR inhibitors that are often 
abundant in these samples. Microbial communities 
obtained from these two methods cluster closely in 
the dendrogram graph, thus are similar.35 
Fusobacterium 16S rRNA gene was amplified by 
PCR using forward primer 785 F 
(5ʹGGATTAGATACCCTGGTAGTC3ʹ) and back-
ward primer BWR1 (5ʹCTCTTTCGTAT 
TAAGACTCCA3ʹ), which specifically amplify the 
16S rRNA genes of both F. nucleatum and 
F. periodonticum, two most closely related oral 
species,36 generating an amplicon containing 
the second half of the 16S rRNA gene, starting 
near position 785, and including part of the internal 
transcribed spacer (ITS) region downstream of the 
16S rRNA gene. PCR amplicons were cloned into 
plasmid pCR2.1-TOPO (Invitrogen) and trans-
formed into competent E.coli (One Shot TOP10, 
Invitrogen, Carlsbad, CA, USA). The bacteria were 
plated onto LB plates containing 50 µg/ml ampicil-
lin and 40 µg/ml 5-bromo-4-chloro-3-indolyl-beta 
-D-galactopyranoside (X-gal). The plasmids were 
purified using Purelink Quick Plasmid DNA 
Miniprep Kit (Invitrogen), followed by Sanger 
sequencing using M13F and M13R primers. The 
number of clones sequenced from each sample is 
listed in Supplementary Table 1.
Quality filtering and sequence alignment
The Sanger sequencing data were converted to fastq 
files using biopython,37 and quality filtered in the 
following manner. Forward and reverse sequences 
were trimmed to 600 bases long, as visual examina-
tion confirmed that this region has high accuracy, 
with Phred > 30. Additionally, 70 bases were 
removed from the ends to eliminate adapter errors. 
Quality summaries for each patient are presented in 
Supplementary Figure 1. Paired ends were then 
merged using vsearch.38 All sequences were aligned 
to the second-half of Fusobacterium 16S rRNA and 
a portion of the internal transcribed spacer (ITS) 
region downstream of the 16S rRNA gene 
using PyNAST,39 This merged sequence was then 
trimmed to remove the ITS region due to its high 
variability, producing a product of 792 bp. The 
sequence counts from each sample are presented 
in Supplementary Table 1. A total of 383 sequences 
remained after quality filtering. These sequences 
are deposited in Genbank under the reference 
number SUB7794064, with MT780937 – 
MT781319 as accession numbers for each indivi-
dual sequences.
Minimum entropy decomposition (MED)
The 792 bp fragments were used for MED and tree 
generation. In order to identify low-level species or 
strains, the aligned sequences were clustered by 
MED,40 an automated version of oligotyping.41 
This method searches for nucleotide positions in 
the input sequence that have high divergence, and 
iteratively decomposes them into groups of 
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sequences, called nodes, which are representative 
sequences used for BLAST search. MED was run 
with parameters of minimum substantive abun-
dance (-M) of 3 and relocation of outliers, with all 
other parameters set to their defaults. One sequence 
was removed due to too low a substantive abun-
dance (1), and another was removed because of 
excess variations in nucleotide sites. A total of 381 
sequences remained for analysis (Supplementary 
Table 1).
Tree generation
Reference fusobacterial sequences from NCBI 
GenBank42 were chosen by acquiring the top two 
BLAST hits for each node. Many of the top two 
sequences were not unique and matched multiple 
nodes. These reference sequences were added to the 
aligned sequences, and phylogenetic relationships 
were determined using FastTree.43 The tree was 
plotted using ggtree,44 using reference sequences 
obtained from BLAST for subspecies identities. 
Node colorations were assigned manually based 
on monophyletic relationships in the tree.
Ecological and statistical analyses
The difference between communities from different 
sites and/or subjects was quantified by the Bray– 
Curtis dissimilarity45 and their statistical signifi-
cance estimated using ANOSIM.46 Rarefaction 
curves with the Chao1 richness as the dependent 
variable were used to compare species richness 
between sites.47,48 This was accomplished by pool-
ing reads according to sample sites, sampling reads 
without replacement from each site pools one at 
a time, and then calculating the Chao1 diversity 
using the estimate_richness function in phyloseq.49 
Mann–Whitney tests were performed using the 
Wilcox test function in base R. Kruskal–Wallis 
tests were performed with the kruskal.test function. 
ANOSIM was run using the anosim function from 
vegan.50 Heatmaps, rarefaction curves, and PCoA 
plots were made using ggplot2,51 all of which were 
performed using R 3.3.4. Unless otherwise noted, 
all analysis was performed using the matched sal-
iva, gastric aspirate, and colon or ileal aspirate 
samples (sample triads) from the six individuals 
with complete sampling.
Enrichment analysis
Enrichment of a certain node at a body site was 
performed using the binomial test, using the binom. 
test function.52 In brief, for each node (i.e. strain), 
the site with the greatest abundance was compared 
pairwise to the other two body sites, using a one 
sided (greater) binomial test with p = 1/3, the num-
ber of trials (N) equal to the abundance of the node. 
If it was significantly greater relative to both of the 
other two body sites, it was marked as significantly 
enriched in that body site.
Results
Long-read sequences for assessing diversity of 
Fusobacterium
Fusobacteria-specific PCR primers, combined with 
MED40 allowed for fine-scale interrogation of fuso-
bacterial diversity. MED is an automated version of 
oligotyping41 that uses single nucleotide differences 
in the 16S rRNA gene to group sequences into sub- 
groups called oligotypes. The group partitioning 
was aided by the ability to utilize a 792 bp amplicon 
of the 16S rRNA gene. This is due to the observa-
tion that fusobacterial 16S rRNA has sites of high 
entropy along the entire amplicon (Supplementary 
Figure 2), which cannot be resolved by only asses-
sing a 250 bp fragment, as is typical in Illumina 
paired-end sequencing.53 More sites of high 
entropy allow for increased power in discerning 
sequences, allowing for the recovery of unique 
fusobacterial sequences, or nodes. After quality 
control and performing MED, 381 sequences 
formed 28 unique nodes, each representing 
a unique strain of fusobacteria.
Evaluation of the completeness of sampling and 
alpha diversity
In all sequencing and all sampling-based methods, 
it is not unusual to have missing members of the 
microbial community due to limitations of sam-
pling. This can result in a misleading presentation 
of diversity, as part of the community is absent. The 
relationship between sampling and completeness is 
often graphically shown using a rarefaction 
curve,47,54 which plots diversity of the community 
as a function of random samples from all samples. 
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Diversity increases with the number of samples 
collected, until a point of saturation is reached 
where more sampling does not meaningfully 
increase diversity, as one has sampled almost all 
members of the community. Using Chao1 richness, 
which is a robust richness estimator for microbial 
count data,47,48 we examined the sampling depth of 
each body site (Figure 1). The rarefaction curve 
saturates for each body site, indicating that our 
sampling scheme has captured a relatively complete 
fusobacterial community. For each patient sepa-
rately, the overall richness of sequences (alpha 
diversity) was not significantly different across 
sampling sites (Kruskal–Wallis rank sum test, 
p = .0625 on Chao1 richness), and for each sam-
pling site, the difference was not significant 
between different individuals (Kruskal–Wallis 
rank sum test, p = .7673 on Chao1 richness) 
(Supplementary Figure 3). However, when all 
sequences at each body site were pooled from all 
patients, there were significant differences in the 
overall sequence richness (alpha diversity) by sam-
pling sites. The predicted Chao1 richness from 
saliva is seen to be significantly greater than that 
from gastric or colon/pouch, as it lies above the 
standard error of the latter (p < 0.05, Figure 1), 
indicating a much richer meta-community of 
unique nodes/strains.
Phylogenetic placement of Fusobacterium 16S rRNA 
sequences
Assigning taxonomy to the 28 nodes/strains will 
allow us to determine if extra-oral translocation of 
Fusobacterium is particular to the subspecies and/ 
or strain levels. Most 16S rRNA-based classification 
methods group at the species level. Therefore, we 
determined taxonomy by creating a phylogenetic 
tree that combined existing fusobacterial sequences 
from NCBI and the MED nodes (Figure 2). 
Different species and subspecies appear to cluster 
monophyletically, which indicates that fusobacter-
ial subspecies classification is consistent with 16S 
rRNA sequence diversity. Further, due to the 
monophyletic groups, we are confident in the 
assignment of nodes to putative clades, as there 
appears to be little mixing between different sub-
species in the tree structure that would make clas-
sification difficult. This allows us to assess the nodes 
and their translocation ability in the context of 
fusobacterial phylogeny, to know which species 
and subspecies each strain/node belongs.
Fusobacterium community compositions vary 
according to body sites
Fusobacterial communities from different indivi-
duals and at different body sites were compared. 
Using complete triads (matching saliva, gastric 
aspirate, colon/pouch aspirate samples) from 3 
IBD patients and 3 healthy controls, we found sig-
nificant compositional differences (beta diversity) 
at different body sites (ANOSIM R: 0.3652, 
Figure 1. Rarefaction curves generated from pooled sequences 
from 3 IBD patients and 3 healthy controls with matching sample 
triads, i.e. saliva, gastric aspirate, colon/pouch aspirate. Lines are 
drawn by LOESS (locally estimated scatterplot smoothing), with 
lighter colored areas surrounding the lines as the standard error 
intervals. Rarefaction curves averaged across individual samples 
can be seen in Supplementary Figure 3. The pool of saliva 
samples is more diverse compared to gastric and colon/pouch 
samples.
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Figure 2. Phylogenetic tree combining the nodes discerned by Minimum Entropy Decomposition (MED) with reference sequences 
obtained from BLAST. This approach is used to determine the identity of the unknown sequences. Almost all nodes fall into 
monophyletic clades based on either species or subspecies, which makes phylogeny determination straightforward. The tree is 
colored by the inferred clades, with names shown to the left of the colored clade.
Figure 3. Principle coordinates analysis (PCoA) of Fusobacterium communities of all samples. Each symbol represents the community of 
one body site from one individual, and the distance between them is based upon the Bray-Curtis dissimilarity. The ellipses drawn 
around the points represent 95% confidence intervals assuming a multivariate t-distribution for each body site using the six matching 
sample triads. 1–3, healthy controls; 4–6, IBD patients (see Table 1 for subject description). The light pink dots are saliva samples from 7 
additional IBD patients without matching gastric or colon/pouch aspirates, all of which fall into the pink ellipse, confirming the 
predicted variability. Based on the variability of these samples, fusobacterial communities are more closely related in the gastric and 
colon/pouch than in saliva. Using the matching triads (saliva, gastric aspirate and colon/pouch aspirate) from 6 individuals, we found 
that different body sites harbor significantly different communities (ANOSIM R: 0.3652, p = .003).
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p = .003). However, this difference is not related to 
disease status when comparing IBD patients to 
healthy controls (ANOSIM R: −0.08182, 
p = .8512). Furthermore, there was no difference 
between patients (ANOSIM R = −0.0733, p = .86). 
Overall compositions appeared to vary most 
between body sites, as seen in Figure 3. By grouping 
together body sites from the six triads, we generated 
confidence ellipses representing 95% confidence 
intervals to demonstrate overall sample variability. 
Gastric and colon/pouch samples cluster together, 
while saliva samples have much wider variation. 
For validation, the seven additional saliva samples 
fell within the salivary ellipse, regardless of the 
disease status, i.e. active IBD or IBD in remission 
(Figure 3 and Table 1). Interestingly, when the 
saliva samples from 3 healthy subjects were com-
pared with those from the 10 IBD patients, differ-
ence between the two groups was detected 
(ANOSIM R=0.2549, p = .0412).
The high variability of the salivary composition is 
further demonstrated when comparing the average 
difference of sample types. The median Bray–Curtis 
distance between any two saliva samples is signifi-
cantly larger than the distance between any two 
gastric or colon/pouch samples (Figure 4). 
Furthermore, saliva samples exhibit an increased 
trend of dissimilarity from other sampling sites, 
while gastric and colon/pouch samples are of similar 
distance to each other. The reduced composition 
diversity of Fusobacterium in gastric and colon/ 
pouch compared to saliva may indicate the selective 
pressure during translocation in the GI tract.
When each body site was assessed by subspecies, 
no significant enrichment of any subspecies was 
observed at any site (Figure 5). However, individual 
nodes/strains show preponderance in certain body 
sites. When comparing the variations at the node/ 
strain level, a few exhibited significant differences 
between body sites (Figure 6). Heatmaps of strains/ 
Figure 4. The average Bray-Curtis dissimilarity of Fusobacterium communities between body sites. The median distance between body 
sites from different individuals is calculated using matched saliva, gastric aspirate, and colon/pouch aspirate samples. For example, the 
upper-left box is the average dissimilarity of a saliva sample to other saliva samples. The oral Fusobacterium communities are 
significantly more dissimilar from each other than from the gastric (Mann-Whitney U-Test, p = 0.036) or colon/pouch (Whitney 
U-Test p = 2.588 10−6) communities, indicating that there is significantly more variation between oral samples than the GI samples.
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nodes at the patient and site levels, respectively, are 
shown in Supplementary Figure 4. The saliva sam-
ples had most of the nodes seen across all body 
sites, while colon/pouch had the fewest. Among 
these, nodes 30, 4, 35, 57, 26, 72, 69, and 45 were 
enriched in the colon/pouch compared to saliva, 
although the difference is not statistically signifi-
cant, possibly due to limited sample size (Figure 6). 
In contrast, nodes 56, 36, 49, 52, and 71 were 
diminished or reduced when translocating from 
saliva to the GI locations. Node 25 was significantly 
enriched in gastric but diminished in the lower GI 
site. At the subspecies level, it appears that subsp 
animalis tends to persist through colon/pouch, 
while subsp vincentii was defective in colonizing 
the lower GI tract. F. periodonticum seems to per-
sist through the GI tract. These results indicate that 
migration of Fusobacterium in the GI tract is 
a selective process, which occurs predominantly at 
the strain level, rather than at the subspecies level.
Discussion
Although oral-fecal transmission has been well 
documented,55 this is the first study to systemically 
compare fusobacterial diversity in the oral and GI 
system. We chose saliva as an oral sample not only 
because it is easy to obtain, but also because the 
salivary microbial community is more stable than 
that of dental plaque.56 Given the heterogeneity of 
F. nucleatum at the species and subspecies levels, 
we used MED to analyze 16S rRNA genes to 
achieve resolution beyond the subspecies level. 
Fusobacterium 16S rRNA genes were amplified by 
Figure 5. Heatmap of Fusobacterium grouped by body site at the clade level as determined by phylogenetic tree. This corresponds to 
the subspecies level for F. nucleatum and the species level for F. periodonticum. F. periodonticum is the most abundant clade in each 
body site. No clades were significantly enriched by the binomial test.
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PCR, followed by cloning and Sanger sequencing. 
The method employed in our study is labor inten-
sive, but it generates highly accurate long reads, 
allowing for the needed resolution. The primers 
used in this study, which amplify all five recognized 
subspecies of F. nucleatum, as well as 
F. periodonticum, can be used in future studies in 
combination with high-throughput long-read 
sequencing technology, e.g. Pacific Biosciences 
(PacBio) SMRT sequencing, which would allow 
for a large number of reads per sample to be gen-
erated in a high-throughput manner. Nevertheless, 
with 381 paired-end reads in the current study, we 
have shown that Fusobacterium differ between 
body sites. Our study also reveals the phylogenetic 
relationship between F. nucleatum subsepcies.
Using matched oral, gastric and colon/pouch sam-
ples from IBD patients and healthy controls, along 
with saliva samples from additional IBD patients, we 
have observed emerging patterns. Fusobacterium 
community compositions in saliva are the most 
diverse, significantly more so than in the GI loca-
tions, and may be related to the disease status. 
Diversity in the GI sites is signficantly reduced, pos-
sibly due to intrinsic selective pressure affecting 
Fusobacterium colonization, e.g. acid in the stomach, 
digestive enzymes in the small intestine, and coloni-
zation resistance in the colon. Only those that are 
capable to overcome such environmental obstacles 
can colonize the GI niches. The similarity between 
the gastric and colon/pouch communities was unli-
kely due to polyethylene glycol-based colonic pre-
paration because it would have altered the oral 
community as well. Instead, it suggests that gastric 
acid may be a major limiting factor for fusobacterial 
translocation down the GI tract. This is consistent 
Figure 6. Heatmap of the abundance of distinct Fusobacterium nodes at each body site, grouped by subspecies. Enrichment was tested 
using the binomial test with a Benjamini-Hochberg correction, and significance is indicated by a star. Individual nodes have differing 
abundance patterns across body sites. F. nucleatum subsp animalis tends to persist through colon, while subsp vincentii is least likely to 
colonize the colon. Heatmaps by patients and body sites are shown in Supplementary Figure 4.
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with previous report that gastric acid affects the 
infectious potential of ingested bacterial pathogens.57
Although subsp animalis tends to persist though the 
GI tract, and subsp vincentii appears to be least likely to 
colonize the colon/pouch, no clades are significantly 
enriched by the binomial test. Instead, the adaptation 
of Fusobacterium to gastro intestine appears to be at 
the strain/node level, rather than at the species or 
subspecies levels. This is consistent with a previous 
report that most subspecies of Fusobacterium are 
detected in CRC.28 Therefore, subspecies classification 
alone is not sufficient to identify the translocation and 
disease potentials of individual Fusobacterium strains. 
Future studies will investigate specific virulence factors 
associated with the transmissible strains/nodes to 
understand how the translocation occurs.
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